Bioforce Nanosciences Holdings Income Statement (2019-2026) | BFNH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Selling, General & Administrative (Quarter)	0.02M	0.01M	0.01M	0.03M	0.01M	0.02M	0.01M	0.02M	0.01M	0.01M	0.01M	0.03M	0.01M	0.02M	0.02M	0.03M	0.02M	0.01M		0.01M
Other Operating Expenses (Quarter)	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.43M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M		0.11M
Operating Expenses (Quarter)	0.12M	0.11M	0.12M	0.13M	0.12M	0.12M	0.44M	0.13M	0.11M	0.11M	0.11M	0.13M	0.11M	0.12M	0.12M	0.13M	0.12M	0.12M		0.12M
Operating Income (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M
EBIT (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M
Non-operating items
Other Non Operating Income (Quarter)																-0.80M
Non Operating Income (Quarter)																-0.80M				0.02M
Net income details
EBT (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M
Profit After Tax (Quarter)	-0.12M	-0.11M	-0.12M	-0.13M	-0.12M	-0.12M	-0.11M	-0.13M	-0.11M	-0.11M	-0.11M	-0.13M	-0.11M	-0.12M	-0.12M	-0.94M	-0.12M	-0.12M		-0.10M
Income from Continuing Operations (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M
Consolidated Net Income (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M
Income towards Parent Company (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M
Net Income towards Common Stockholders (Quarter)												-0.13M	-0.11M	-0.12M		-0.94M	-0.12M	-0.12M		-0.10M
Additional items
EPS (Basic) (Quarter)			-0.01	29.27M			-0.03				-0.01	0.00	0.00	0.00	-0.01	-0.03	0.00	0.00		0.00
EPS (Weighted Average and Diluted) (Quarter)							-0.03				-0.01	0.00	0.00	0.00	-0.01	-0.03	0.00	0.00		0.00
Shares Outstanding (Weighted Average) (Quarter)	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	32.25M	33.52M	33.10M	33.21M	33.52M
Shares Outstanding (Diluted Average) (Quarter)		29.27M			29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	29.27M	32.25M	32.89M	33.52M	33.21M	33.52M
EBITDA (Quarter)													-0.11M	-0.12M		-0.13M	-0.12M	-0.12M		-0.12M

Research Tools

Developers

Bioforce Nanosciences Holdings Income Statement (2019-2026) | BFNH

Research Tools

Developers

Bioforce Nanosciences Holdings Income Statement (2019-2026) | BFNH

Create an account

Sign In

Reset Password